Scientific Evidence

Business

Pfizer's $23 Billion Oncology Bet: CEO Albert Bourla's Post-Pandemic Quest to 'Save the World from Cancer'

After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.

Jan 30, 2026

Business

Maxim Group Reiterates Bullish Stance on Strive (ASST), Sees 50% Upside to $1.50 Target

Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.

Jan 30, 2026

Business

Thermo Fisher Beats Q4 Estimates on Product Launches, Acquisitions; Shares Dip Amid Broader Concerns

Thermo Fisher Scientific posted stronger-than-expected Q4 revenue and profit, driven by new products and strategic deals. However, the stock fell as investors weighed pressures in key academic and government markets against the company's solid 2026 outlook.

Jan 30, 2026

World

Pakistan Military Claims Major Strike: 41 Militants Killed in Balochistan Operations, Accuses Indian Backing

Pakistan's military says it has killed 41 armed fighters in two separate raids in restive Balochistan province, alleging—without presenting evidence—that the militants were supported by regional rival India. The operations come amid a surge in violence in the region.

Jan 30, 2026

US

Judicial Independence Under Scrutiny: State AGs Demand Congressional Probe Into Climate Bias Allegations in Federal Bench Guide

A coalition of 22 state attorneys general is urging Congress to expand an investigation into potential ideological influence on the federal judiciary, citing concerns over a newly updated judicial reference manual they claim promotes a climate activist agenda.

Feb 3, 2026

Business

AI Job Displacement: More Hype Than Reality, Yale Study Suggests, as 'AI-Washing' Concerns Mount

Amid widespread anxiety over AI-driven job losses, a new report from the Yale Budget Lab finds little evidence of large-scale labor market disruption, raising questions about whether 'AI-washing' is being used to justify corporate layoffs.

Feb 2, 2026

Business

The Inflation Mismatch: Why Social Security's Annual Raise Falls Short for Millions of Seniors

While October's COLA announcement brings temporary relief, a growing body of evidence suggests the formula used to calculate Social Security adjustments fails to reflect the real-world expenses of retirees, creating a persistent and compounding budget gap.

Feb 2, 2026

Business

Grail Seeks FDA Green Light for Pioneering Multi-Cancer Blood Test, Paving Way for Broader Insurance Coverage

The biotech company Grail has formally submitted its Galleri test for FDA premarket approval, a critical step that could unlock widespread insurance reimbursement and integrate the multi-cancer screening tool into mainstream preventive care.

Feb 2, 2026

Business

Cynosure Lutronic's Mosaic 3D Laser Platform Clears Key EU Regulatory Hurdle, Paving Way for Broader Adoption

The European CE Mark under the stringent MDR has been granted for Cynosure Lutronic's innovative fractional resurfacing system, designed to improve safety and patient comfort through advanced cooling and precision technology.

Feb 2, 2026

Business

Standex Hits Inflection Point: Record Margins and $100M+ Growth Forecast Signal Strategic Pivot

Standex International Corporation (NYSE: SXI) capped off its fiscal 2025 with a powerful fourth quarter, announcing record adjusted operating margins of 20.6% and laying out an ambitious roadmap for over $100 million in revenue growth for the coming year. CEO David Dunbar declared a "turning point" for the diversified industrial manufacturer, citing scaled growth drivers in electronics, engineering technologies, and fast-growing markets like grid modernization and defense.

Jan 30, 2026

Business

ExxonMobil's Q4 Profits Dip Amid Market Headwinds, But Long-Term Strategy Shows Resilience

ExxonMobil reported a 14% year-on-year decline in fourth-quarter net profit, pressured by lower crude prices and chemical margins. Despite the quarterly drop, the energy giant highlighted record production levels, robust cash flow, and continued heavy returns to shareholders as evidence of its strengthened operational foundation.

Jan 30, 2026

Business

Korro Bio Unveils RNA-Editing Therapy KRRO-121, Aiming to Redefine Ammonia Control for Rare Metabolic and Liver Disorders

At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.

Jan 30, 2026

Business

Acadia's Rett Syndrome Drug Hits European Regulatory Snag, Company to Appeal Decision

Acadia Pharmaceuticals faces a setback as European regulators issue a negative opinion on its Rett syndrome therapy trofinetide, casting uncertainty over its EU approval pathway and highlighting the challenges of bringing rare disease treatments to new markets.

Feb 3, 2026

Business

Azenta Earnings on Deck: Can the Life Sciences Firm Beat Flat Revenue Forecasts?

Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.

Feb 3, 2026

US

Medical Examiner Rules Minneapolis ICU Nurse's Death a Homicide, Contradicts Official Account

The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.

Feb 3, 2026

Business

Houlihan Lokey Poised for 2026 Gains as Market Volatility Fuels Demand for M&A and Restructuring Expertise

Amid forecasts of rising economic stress and market volatility in 2026, investment bank Houlihan Lokey (NYSE: HLI) is attracting bullish attention for its dual strength in M&A advisory and corporate restructuring. Analysts point to its defensive positioning and potential to capture outsized gains in a shifting financial landscape.

Feb 3, 2026

Business

Paychex Navigates Post-Acquisition Turbulence: A Deep Dive into the Bull Case Amid Market Skepticism

Despite a significant stock pullback following its transformative $4.1 billion acquisition of Paycor, Paychex (PAYX) presents a compelling case for patient investors. This analysis explores the strategic rationale behind the deal, near-term integration pressures, and the long-term defensive appeal of its recurring-revenue model in a volatile market for small-business services.

Feb 3, 2026

Business

ASGN Q4 Earnings Preview: Can the IT Services Firm Reverse Its Revenue Slide?

ASGN Inc. is set to report its fourth-quarter financial results after the bell on Wednesday, with Wall Street anticipating another year-over-year revenue decline. Investors will scrutinize the performance for signs of stabilization in a competitive sector.

Feb 3, 2026

World

Royal Family Under Scrutiny as Crown Princess's Son Faces Serious Criminal Trial

Marius Borg Høiby, the son of Norway's Crown Princess Mette-Marit, is set to stand trial on Tuesday, facing a litany of charges including rape, domestic violence, and drug possession. The case marks a profound crisis for the modern Norwegian monarchy, unfolding against a backdrop of other royal controversies and health concerns.

Feb 3, 2026

US

DHS Chief Noem to Face Congress Amid Scrutiny Over Minnesota Immigration Operations

Homeland Security Secretary Kristi Noem will testify before House and Senate committees in March, as lawmakers probe the administration's immigration enforcement tactics following the fatal shootings of two U.S. citizens in Minnesota.

Feb 3, 2026